Sector Alpha Week of 2026-08-05
20-quarter listed-company comparison

Chemicals - Inorganic Stocks in India

Chemicals - Inorganic: Deepak Nitrite Ltd owns the largest revenue base; Fischer Medical Ventures Ltd has the fastest current growth.

01 · the index people search for

Nifty Chemicals - Inorganic Index — Constituents & Performance

The Chemicals - Inorganic companies below are the listed Indian Chemicals - Inorganic universe this page tracks — the same constituent set people search for as the Nifty Chemicals - Inorganic index. Every figure is equal-weighted across those companies, so one large constituent cannot set the reading. Each number carries its own as-of date.

02 · the sector itself · before any single company

How has Chemicals - Inorganic moved against NIFTY 500?

The line below covers up to 5.2 years and opens on the 5Y view; the buttons cut it shorter. Over the most recent two of them this sector is 26% ahead of NIFTY 500. Earnings across its companies grew 5% on average over the last four reported quarters — close to flat. It has been ahead of NIFTY 500 on a rolling three-month view for 17 weeks running.

FADING · −2 in 4w✓Price up, without the fundamentals confirming4 of 9 companies ahead of NIFTY 500 by 5% or more over three months2 are 20% or more behind over a year while earnings grew 20% or more

RS ↑17w · 5/9 >200d (+1) · 4/9 lead (−2) · EPS 6/9↑

200500100020262025202420232022 1328333 TRAILING 12-MONTH EPS · 100 AT THE START0100103Sep 23Mar 24Sep 24Mar 25Sep 25Mar 26Jun 2023 · trailing 12-month earnings per share at 100, against 100 at the start · down 23.2% on a year ago · 3 reporting · thin coverageSep 2023 · trailing 12-month earnings per share at 100, against 100 at the start · up 2.8% on a year ago · 7 reportingDec 2023 · trailing 12-month earnings per share at 98, against 100 at the start · down 1.8% on a year ago · 8 reportingMar 2024 · trailing 12-month earnings per share at 91, against 100 at the start · down 13.7% on a year ago · 8 reportingJun 2024 · trailing 12-month earnings per share at 90, against 100 at the start · down 17.3% on a year ago · 8 reportingSep 2024 · trailing 12-month earnings per share at 90, against 100 at the start · down 14.0% on a year ago · 8 reportingDec 2024 · trailing 12-month earnings per share at 98, against 100 at the start · down 1.9% on a year ago · 8 reportingMar 2025 · trailing 12-month earnings per share at 82, against 100 at the start · up 10.0% on a year ago · 8 reportingJun 2025 · trailing 12-month earnings per share at 76, against 100 at the start · up 7.7% on a year ago · 8 reportingSep 2025 · trailing 12-month earnings per share at 86, against 100 at the start · up 8.8% on a year ago · 8 reportingDec 2025 · trailing 12-month earnings per share at 85, against 100 at the start · up 2.0% on a year ago · 8 reportingMar 2026 · trailing 12-month earnings per share at 103, against 100 at the start · up 2.6% on a year ago · 7 reportingNot reported yet — earnings trail price by a quarter or two103 · Mar 26No earnings on file this far back — the price series reaches further than the filings doNO EARNINGS ON FILE
200500100020262025202420232022 1328333 TRAILING 12-MONTH EPS · 100 AT THE START0100103Mar 24Mar 25Mar 26Jun 2023 · trailing 12-month earnings per share at 100, against 100 at the start · down 23.2% on a year ago · 3 reporting · thin coverageSep 2023 · trailing 12-month earnings per share at 100, against 100 at the start · up 2.8% on a year ago · 7 reportingDec 2023 · trailing 12-month earnings per share at 98, against 100 at the start · down 1.8% on a year ago · 8 reportingMar 2024 · trailing 12-month earnings per share at 91, against 100 at the start · down 13.7% on a year ago · 8 reportingJun 2024 · trailing 12-month earnings per share at 90, against 100 at the start · down 17.3% on a year ago · 8 reportingSep 2024 · trailing 12-month earnings per share at 90, against 100 at the start · down 14.0% on a year ago · 8 reportingDec 2024 · trailing 12-month earnings per share at 98, against 100 at the start · down 1.9% on a year ago · 8 reportingMar 2025 · trailing 12-month earnings per share at 82, against 100 at the start · up 10.0% on a year ago · 8 reportingJun 2025 · trailing 12-month earnings per share at 76, against 100 at the start · up 7.7% on a year ago · 8 reportingSep 2025 · trailing 12-month earnings per share at 86, against 100 at the start · up 8.8% on a year ago · 8 reportingDec 2025 · trailing 12-month earnings per share at 85, against 100 at the start · up 2.0% on a year ago · 8 reportingMar 2026 · trailing 12-month earnings per share at 103, against 100 at the start · up 2.6% on a year ago · 7 reportingNot reported yet — earnings trail price by a quarter or two103No earnings on file this far back — the price series reaches further than the filings do
Chemicals - Inorganic, equal-weighted, based at 200 NIFTY 500, same base, same start trailing 12-month earnings per share rising falling

Both lines start at 200 in the same week, so the distance between them is the whole story: the sector line is an equal-weighted index of its 9 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member rebased to 100 at the start and the sector taking the median — so a price line pulling away from flat bars is a re-rating, not earnings. A bar turns red when that figure is lower than the quarter before. Rules are fixed and applied identically everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover any point to read both values and the gap. This is a description of what the numbers did, not advice.

03 · sector relative strength, before individual stocks

Is Chemicals - Inorganic outperforming NIFTY 500?

Chemicals - Inorganic has underperformed NIFTY 500 by 7.1% over the last 52 weeks. Over 13 weeks the gap is a lead of 6.6%. 4 of 9 covered companies currently beat NIFTY on Mansfield relative strength, so leadership inside the sector is selective. Tanfac Industries Ltd is the strongest against the sector itself at +28.4%. Readings are as of 2026-07-19.

+6.6%Sector vs NIFTY 500 · 13 weeks
-7.1%Sector vs NIFTY 500 · 52 weeks
4/9Stocks leading NIFTY 500
2/9Stocks leading sector

Sector metric: 33.4 as of 2026-07-19 · CONSOLIDATION · falling.

The central tension: the companies with the most scale are not necessarily the companies creating the most change.

Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.

Bottom line

Chemicals - Inorganic has underperformed NIFTY 500 by 7.1% over 52 weeks and 6.6% over 13 weeks. 4 of 9 covered companies beat NIFTY on Mansfield relative strength, while 2 of 9 beat the sector itself. Deepak Nitrite Ltd leads with revenue of ₹7,887 crore, based on 9 of 9 comparable companies through Mar 2026.

Companies
9
complete canonical membership
Combined market value
₹43.6K Cr
Deepak Nitrite Ltd
Revenue growing
6/8
positive TTM year-on-year growth
Beating NIFTY 500
4/9
positive Mansfield relative strength
Comparing 5 of 9
04 · research priority, made explicit

4-Factor Sector Score

An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.

Growth & earnings · 35%Capital efficiency · 25%Valuation · 20%Relative strength · 20%
Indo Borax & Chemicals Ltd has the strongest current balance of earnings trajectory, business quality, valuation and price confirmation, with 82.8% evidence confidence.
Sree Rayalaseema Hi-Strength Hypo Ltd looks inexpensive relative to peers or its own history, but its earnings trajectory has not yet earned the valuation signal.
Tanfac Industries Ltd has stronger price confirmation than earnings confirmation; that is a research prompt, not permission to chase.
How this score is built, and what the marks mean

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Indo Borax & Chemicals LtdINDOBORAX 66.5/100Favorable setup83% evidence LEADER 23.4/35 Revenue 22.7% · PAT 19.1% · OPM change 0 pp 83% evidence 17.6/25 ROCE 15.4% · OPM 20% 95% evidence 6.6/20 P/E 33.1× · PEG — 50% evidence 18.9/20 RS sector 23% · RS bench 32.3% · 1Y 29.8%12 of 12 weeks ahead 100% evidence
Exact sum: 23.4 + 17.6 + 6.6 + 18.9 = 66.5 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
2Tanfac Industries LtdTANFACIND 54.5/100Mixed-positive evidence82% evidence BREAKING OUT 10.8/35 Revenue 13.2% · PAT -29.2% · OPM change -1 pp 95% evidence 18.5/25 ROCE 23.7% · OPM 15% 76% evidence 6.2/20 P/E 96.1× · PEG — 50% evidence 19.0/20 RS sector 28.4% · RS bench 38.1% · 1Y 39.2%9 of 12 weeks ahead 100% evidence
Exact sum: 10.8 + 18.5 + 6.2 + 19 = 54.5 · Decision use: Price leads the evidence: RS versus the benchmark is 38.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
3J.G.Chemicals LtdJGCHEM 53.0/100Mixed-positive evidence70% evidence TURNING 17.4/35 Revenue 14.6% · PAT 1.5% · OPM change -1 pp 83% evidence 14.3/25 ROCE 18.1% · OPM 8% 95% evidence 10.4/20 P/E 30× · PEG — 15% evidence 10.9/20 RS sector -3.5% · RS bench 22.9% · 1Y 6.1%10 of 10 weeks ahead 70% evidence
Exact sum: 17.4 + 14.3 + 10.4 + 10.9 = 53 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Ganesh Benzoplast LtdGANESHBE 49.5/100Mixed-negative evidence62% evidence TURNING 11.7/35 Revenue 9.6% · PAT 97.3% · OPM change -14 pp 62% evidence 14.3/25 ROCE 14.6% · OPM 18% 95% evidence 11.1/20 P/E 12.1× · PEG — 15% evidence 12.4/20 RS sector -2.3% · RS bench 23.2% · 1Y 16.7%9 of 11 weeks ahead 70% evidence
Exact sum: 11.7 + 14.3 + 11.1 + 12.4 = 49.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Sree Rayalaseema Hi-Strength Hypo LtdSRHHYPOLTD 47.5/100Mixed-negative evidence77% evidence ASLEEP 15.3/35 Revenue 4.5% · PAT 1.1% · OPM change -3 pp 83% evidence 11.5/25 ROCE 14% · OPM 8% 95% evidence 14.3/20 P/E 8.3× · PEG — 50% evidence 6.4/20 RS sector -11.3% · RS bench -6.9% · 1Y -24.5%6 of 10 weeks ahead 70% evidence
Exact sum: 15.3 + 11.5 + 14.3 + 6.4 = 47.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
6Deepak Nitrite LtdDEEPAKNTR 45.7/100Mixed-negative evidence96% evidence ASLEEP 14.6/35 Revenue -4.8% · PAT -20.9% · OPM change 3 pp 88% evidence 8.8/25 ROCE 11.4% · OPM 18% 100% evidence 15.2/20 P/E 41.1× · PEG 0.61 100% evidence 7.1/20 RS sector -8.5% · RS bench -1.6% · 1Y -12.6%9 of 12 weeks ahead 100% evidence
Exact sum: 14.6 + 8.8 + 15.2 + 7.1 = 45.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
7Fischer Medical Ventures LtdFISCHER 42.1/100Mixed-negative evidence73% evidence TURNING 25.1/35 Revenue 100% · PAT 100% · OPM change -4.1 pp 88% evidence 5.1/25 ROCE 11.4% · OPM 1% 100% evidence 8.9/20 P/E 82.6× · PEG — 15% evidence 3.0/20 RS sector -35.6% · RS bench -32.9% · 1Y -58.8%0 of 11 weeks ahead 70% evidence
Exact sum: 25.1 + 5.1 + 8.9 + 3 = 42.1 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -35.6% and the one-year return is -58.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
8Archean Chemical Industries LtdACI 26.6/100Adverse evidence100% evidence ASLEEP 4.3/35 Revenue -0.4% · PAT -39.9% · OPM change -6 pp 100% evidence 7.3/25 ROCE 7.4% · OPM 21% 100% evidence 12.7/20 P/E 67× · PEG 0.83 100% evidence 2.3/20 RS sector -17.9% · RS bench -11.7% · 1Y -22.4%0 of 12 weeks ahead 100% evidence
Exact sum: 4.3 + 7.3 + 12.7 + 2.3 = 26.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9POCL Enterprises Ltd539195 49.2/100Thin evidence · provisional48% evidence ASLEEP 18.7/35 Revenue — · PAT — · OPM change 0 pp 17% evidence 17.6/25 ROCE 26.4% · OPM 5% 76% evidence 10.8/20 P/E 12.8× · PEG — 15% evidence 2.1/20 RS sector -19.4% · RS bench -13.7% · 1Y -29.4%2 of 12 weeks ahead 100% evidence
Exact sum: 18.7 + 17.6 + 10.8 + 2.1 = 49.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
05 · what price has already done

Market action

Tanfac Industries Ltd has the strongest one-year price move in Chemicals - Inorganic at +39.2%. It also leads on Mansfield relative strength against NIFTY at +38.1%. 4 of 9 covered companies are above zero on that measure. Every line covers 313 weekly closes through 2026-07-31.

Price and relative strength

Every company, the sector's own index and NIFTY 500 all start level on the left edge of the window, so only the distance between the lines counts — the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.

06 · compare level, then change

Revenue Scale & Growth Durability

Deepak Nitrite Ltd has the highest Revenue among the 9 Chemicals - Inorganic companies compared here, at ₹7,887 crore. POCL Enterprises Ltd is next at ₹1,431 crore. Fischer Medical Ventures Ltd has the highest Revenue growth at the 100% top of the scoring scale, so level and change sit with different companies.

What the numbers say: Deepak Nitrite Ltd is the scale leader at ₹7,887 crore, 451.2% ahead of POCL Enterprises Ltd. Fischer Medical Ventures Ltd's growth is stored at the ≥100% scoring cap; the uncapped TTM change is 178.8% from a ₹309 crore base, with 14 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.

LeaderDeepak Nitrite Ltd · ₹7,887 crore
Gap451.2% versus #2 · POCL Enterprises Ltd
Persistence4/8 recent comparable periods
Coverage9/9 companies · 129 observations

Investor read: Deepak Nitrite Ltd is the scale benchmark; Fischer Medical Ventures Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.

This conclusion weakens if: Deepak Nitrite Ltd's growth falls below Fischer Medical Ventures Ltd's for two consecutive comparable reports while operating margin also compresses.

Revenue is compared on a common reported-currency basis. Growth is year-on-year, so seasonality does not masquerade as progress.
Revenuelargest
1Deepak Nitrite Ltd DEEPAKNTR₹7.9K Cr
2POCL Enterprises Ltd 539195₹1.4K Cr
3Archean Chemical Industries Ltd ACI₹1.1K Cr
4J.G.Chemicals Ltd JGCHEM⚠ unverified₹972 Cr
5Tanfac Industries Ltd TANFACIND₹722 Cr
Revenue growthfastest growers
1Fischer Medical Ventures Ltd FISCHER100%
2Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified23%
3J.G.Chemicals Ltd JGCHEM⚠ unverified15%
4Tanfac Industries Ltd TANFACIND13%
5Ganesh Benzoplast Ltd GANESHBE⚠ unverified9.6%
Revenue · company comparison
9/9 level · 8/9 change

On every company-comparison chart on this page: solid lines show level, dotted lines show change when “Both” is selected, and a missing report breaks the line rather than being invented.

All-company data · latest reported quarter

In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.

CompanyRevenueRevenue growthReported
Deepak Nitrite Ltd DEEPAKNTR₹2.1K Cr-2.8%Mar 2026
POCL Enterprises Ltd 539195₹332 Cr-11%Mar 2026
Archean Chemical Industries Ltd ACI₹327 Cr12%Jun 2026
J.G.Chemicals Ltd JGCHEM⚠ unverified₹286 Cr28%Mar 2026
Tanfac Industries Ltd TANFACIND₹187 Cr6.3%Jun 2026
Sree Rayalaseema Hi-Strength Hypo Ltd SRHHYPOLTD⚠ unverified₹163 Cr1.9%Mar 2026
Ganesh Benzoplast Ltd GANESHBE⚠ unverified₹111 Cr11%Mar 2026
Fischer Medical Ventures Ltd FISCHER₹98 Cr99%Mar 2026
Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified₹63 Cr26%Mar 2026
Full 20-quarter history · every available company

Revenue · reported quarter history

Archean Chemical Industries Ltd · ACI

—
₹307 Cr
₹373 Cr
₹400 Cr
₹293 Cr
₹365 Cr
₹382 Cr
₹343 Cr
₹290 Cr
₹413 Cr
₹284 Cr
₹213 Cr
₹240 Cr
₹242 Cr
₹346 Cr
₹292 Cr
₹233 Cr
₹255 Cr
₹301 Cr
₹327 Cr

Deepak Nitrite Ltd · DEEPAKNTR

₹1.7K Cr
₹1.7K Cr
₹1.9K Cr
₹2.1K Cr
₹2.0K Cr
₹2.0K Cr
₹2.0K Cr
₹1.8K Cr
₹1.8K Cr
₹2.0K Cr
₹2.1K Cr
₹2.2K Cr
₹2.0K Cr
₹1.9K Cr
₹2.2K Cr
₹1.9K Cr
₹1.9K Cr
₹2.0K Cr
₹2.1K Cr
—

Fischer Medical Ventures Ltd · FISCHER

—
—
—
—
—
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹21 Cr
₹10 Cr
₹40 Cr
₹12 Cr
₹49 Cr
₹23 Cr
₹86 Cr
₹101 Cr
₹98 Cr
—

Ganesh Benzoplast Ltd · GANESHBE⚠ unverified

—
—
—
—
₹96 Cr
₹99 Cr
₹134 Cr
₹122 Cr
₹103 Cr
₹106 Cr
₹146 Cr
₹88 Cr
₹98 Cr
₹89 Cr
₹100 Cr
₹96 Cr
₹99 Cr
₹105 Cr
₹111 Cr
—

Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified

—
—
—
—
—
₹55 Cr
₹56 Cr
₹55 Cr
₹47 Cr
₹44 Cr
₹45 Cr
₹50 Cr
₹38 Cr
₹38 Cr
₹50 Cr
₹54 Cr
₹58 Cr
₹41 Cr
₹63 Cr
—

J.G.Chemicals Ltd · JGCHEM⚠ unverified

—
—
—
—
—
—
₹194 Cr
₹172 Cr
₹153 Cr
₹161 Cr
₹181 Cr
₹203 Cr
₹212 Cr
₹209 Cr
₹224 Cr
₹218 Cr
₹220 Cr
₹248 Cr
₹286 Cr
—

POCL Enterprises Ltd · 539195

—
—
—
—
—
—
—
—
—
—
—
₹364 Cr
—
—
₹372 Cr
₹372 Cr
₹363 Cr
₹364 Cr
₹332 Cr
—

Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified

—
—
—
—
—
₹301 Cr
₹435 Cr
₹261 Cr
₹226 Cr
₹215 Cr
₹165 Cr
₹169 Cr
₹170 Cr
₹138 Cr
₹160 Cr
₹180 Cr
₹182 Cr
₹141 Cr
₹163 Cr
—

Tanfac Industries Ltd · TANFACIND

—
—
—
—
—
₹99 Cr
₹116 Cr
₹106 Cr
₹81 Cr
₹88 Cr
₹103 Cr
₹95 Cr
₹112 Cr
₹178 Cr
₹172 Cr
₹176 Cr
₹169 Cr
₹173 Cr
₹193 Cr
₹187 Cr

Revenue growth · reported quarter history

Archean Chemical Industries Ltd · ACI

—
—
111%
99%
—
19%
2.4%
-14%
-1.0%
13%
-26%
-38%
-17%
-41%
22%
37%
-2.9%
5.4%
-13%
12%

Deepak Nitrite Ltd · DEEPAKNTR

—
—
—
35%
17%
16%
4.8%
-14%
-9.4%
0.9%
8.4%
23%
14%
-5.3%
2.5%
-13%
-6.4%
3.8%
-2.8%
—

Fischer Medical Ventures Ltd · FISCHER

—
—
—
—
—
—
—
—
—
—
11,450%
—
—
—
137%
132%
118%
760%
99%
—

Ganesh Benzoplast Ltd · GANESHBE⚠ unverified

—
—
—
—
—
—
—
—
7.3%
7.1%
9.0%
-28%
-4.9%
-16%
-32%
9.1%
1.0%
18%
11%
—

Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified

—
—
—
—
—
—
—
—
—
-21%
-20%
-9.1%
-19%
-14%
11%
8.0%
53%
7.9%
26%
—

J.G.Chemicals Ltd · JGCHEM⚠ unverified

—
—
—
—
—
—
—
—
—
—
-6.7%
18%
39%
30%
24%
7.4%
3.8%
19%
28%
—

POCL Enterprises Ltd · 539195

—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
2.2%
—
—
-11%
—

Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified

—
—
—
—
—
—
—
—
—
-29%
-62%
-35%
-25%
-36%
-3.0%
6.5%
7.1%
2.2%
1.9%
—

Tanfac Industries Ltd · TANFACIND

—
—
—
—
—
—
—
—
—
-11%
-11%
-10%
38%
102%
67%
85%
51%
-2.8%
12%
6.3%
07 · compare level, then change

Operating Economics & Margin Trend

Archean Chemical Industries Ltd has the highest OPM among the 9 Chemicals - Inorganic companies compared here, at 21%. Indo Borax & Chemicals Ltd is next at 20%. Deepak Nitrite Ltd has the highest Margin change at +3 percentage points, so level and change sit with different companies. Its OPM series carries 20 reported observations across the 20-quarter window.

What the numbers say: Archean Chemical Industries Ltd leads opm at 21%; Deepak Nitrite Ltd leads margin change at +3 percentage points.

LeaderArchean Chemical Industries Ltd · 21%
Gap5% versus #2 · Indo Borax & Chemicals Ltd
Persistence0/8 recent comparable periods
Coverage9/9 companies · 160 observations

Investor read: Archean Chemical Industries Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current margin change signal.

Operating margin compares operating profit with revenue. Improvement is measured in percentage points, not percentage growth.
OPMhighest
1Archean Chemical Industries Ltd ACI21%
2Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified20%
3Deepak Nitrite Ltd DEEPAKNTR18%
4Ganesh Benzoplast Ltd GANESHBE⚠ unverified18%
5Tanfac Industries Ltd TANFACIND15%
Margin changefastest expanders
1Deepak Nitrite Ltd DEEPAKNTR+3.0 pp
2POCL Enterprises Ltd 5391950.0 pp
3Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified0.0 pp
4J.G.Chemicals Ltd JGCHEM⚠ unverified−1.0 pp
5Tanfac Industries Ltd TANFACIND−1.0 pp
Operating margin · company comparison
9/9 level · 9/9 change
All-company data · latest reported quarter
CompanyOPMMargin changeReported
Archean Chemical Industries Ltd ACI21%−6.0 ppJun 2026
Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified20%0.0 ppMar 2026
Deepak Nitrite Ltd DEEPAKNTR18%+3.0 ppMar 2026
Ganesh Benzoplast Ltd GANESHBE⚠ unverified18%−14.0 ppMar 2026
Tanfac Industries Ltd TANFACIND15%−1.0 ppJun 2026
J.G.Chemicals Ltd JGCHEM⚠ unverified8.0%−1.0 ppMar 2026
Sree Rayalaseema Hi-Strength Hypo Ltd SRHHYPOLTD⚠ unverified8.0%−3.0 ppMar 2026
POCL Enterprises Ltd 5391955.0%0.0 ppMar 2026
Fischer Medical Ventures Ltd FISCHER1.0%−4.1 ppMar 2026
Full 20-quarter history · every available company

OPM · reported quarter history

Archean Chemical Industries Ltd · ACI

42%
38%
43%
40%
40%
44%
51%
39%
33%
35%
31%
33%
31%
33%
26%
27%
27%
21%
15%
21%

Deepak Nitrite Ltd · DEEPAKNTR

23%
20%
22%
17%
14%
16%
18%
12%
17%
15%
14%
14%
15%
9.0%
15%
10%
11%
11%
18%
—

Fischer Medical Ventures Ltd · FISCHER

—
—
—
—
—
—
78%
78%
79%
79%
12%
-2.1%
1.3%
3.2%
5.1%
18%
19%
21%
1.0%
—

Ganesh Benzoplast Ltd · GANESHBE⚠ unverified

13%
17%
17%
22%
21%
24%
17%
21%
25%
23%
14%
29%
25%
30%
32%
30%
22%
21%
18%
—

Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified

27%
25%
27%
28%
22%
32%
28%
22%
22%
21%
25%
33%
24%
27%
20%
23%
18%
21%
20%
—

J.G.Chemicals Ltd · JGCHEM⚠ unverified

—
—
—
—
11%
—
8.0%
3.2%
5.0%
9.0%
9.0%
11%
10%
11%
9.0%
9.0%
8.0%
9.0%
8.0%
—

POCL Enterprises Ltd · 539195

2.9%
1.2%
3.0%
3.4%
5.7%
2.2%
2.4%
3.2%
2.6%
3.9%
4.3%
3.5%
—
—
5.0%
6.0%
5.0%
4.5%
5.0%
—

Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified

12%
16%
10%
9.3%
9.9%
9.0%
15%
13%
12%
10%
16%
15%
17%
14%
11%
15%
15%
12%
8.0%
—

Tanfac Industries Ltd · TANFACIND

21%
24%
15%
16%
17%
23%
22%
23%
19%
17%
16%
16%
24%
28%
21%
16%
16%
15%
16%
15%

Margin change · reported quarter history

Archean Chemical Industries Ltd · ACI

—
—
+19.6 pp
+8.2 pp
−1.3 pp
+5.9 pp
+8.0 pp
−1.2 pp
−7.4 pp
−9.0 pp
−20.0 pp
−6.0 pp
−2.0 pp
−2.0 pp
−5.0 pp
−6.0 pp
−4.0 pp
−12.0 pp
−11.0 pp
−6.0 pp

Deepak Nitrite Ltd · DEEPAKNTR

−4.9 pp
−6.7 pp
−9.2 pp
−12.3 pp
−9.2 pp
−4.4 pp
−3.9 pp
−5.3 pp
+3.2 pp
−1.0 pp
−4.0 pp
+2.0 pp
−2.0 pp
−6.0 pp
+1.0 pp
−4.0 pp
−4.0 pp
+2.0 pp
+3.0 pp
—

Fischer Medical Ventures Ltd · FISCHER

—
—
—
—
—
—
—
—
—
—
−65.7 pp
−79.9 pp
−77.7 pp
−75.8 pp
−7.0 pp
+20.3 pp
+17.5 pp
+18.2 pp
−4.1 pp
—

Ganesh Benzoplast Ltd · GANESHBE⚠ unverified

−25.5 pp
−13.7 pp
−0.9 pp
−0.2 pp
+8.3 pp
+7.1 pp
−0.2 pp
−0.7 pp
+4.0 pp
−1.0 pp
−3.0 pp
+8.0 pp
0.0 pp
+7.0 pp
+18.0 pp
+1.0 pp
−3.0 pp
−9.0 pp
−14.0 pp
—

Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified

+0.4 pp
−3.5 pp
−7.7 pp
−1.2 pp
−4.8 pp
+7.8 pp
+0.6 pp
−6.5 pp
−0.4 pp
−11.3 pp
−3.0 pp
+11.0 pp
+2.0 pp
+6.0 pp
−5.0 pp
−10.0 pp
−6.0 pp
−6.0 pp
0.0 pp
—

J.G.Chemicals Ltd · JGCHEM⚠ unverified

—
—
—
—
—
—
—
—
−5.6 pp
—
+1.0 pp
+7.8 pp
+5.0 pp
+2.0 pp
0.0 pp
−2.0 pp
−2.0 pp
−2.0 pp
−1.0 pp
—

POCL Enterprises Ltd · 539195

−0.3 pp
−2.4 pp
+1.3 pp
+1.4 pp
+2.8 pp
+1.0 pp
−0.6 pp
−0.1 pp
−3.2 pp
+1.7 pp
+1.9 pp
+0.3 pp
—
—
+0.7 pp
+2.5 pp
—
—
0.0 pp
—

Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified

−5.6 pp
−1.7 pp
+1.7 pp
−0.2 pp
−2.0 pp
−6.8 pp
+4.7 pp
+3.7 pp
+2.1 pp
+1.0 pp
+1.0 pp
+2.0 pp
+5.0 pp
+4.0 pp
−5.0 pp
0.0 pp
−2.0 pp
−2.0 pp
−3.0 pp
—

Tanfac Industries Ltd · TANFACIND

−4.6 pp
−14.9 pp
+12.3 pp
−16.0 pp
−4.1 pp
−0.6 pp
+7.5 pp
+6.6 pp
+2.5 pp
−6.0 pp
−6.0 pp
−7.0 pp
+5.0 pp
+11.0 pp
+5.0 pp
0.0 pp
−8.0 pp
−13.0 pp
−5.0 pp
−1.0 pp
08 · compare level, then change

Profit Scale & Acceleration

Deepak Nitrite Ltd has the highest Net profit among the 9 Chemicals - Inorganic companies compared here, at ₹551 crore. Archean Chemical Industries Ltd is next at ₹95 crore. Fischer Medical Ventures Ltd has the highest Profit growth at the 100% top of the scoring scale, so level and change sit with different companies.

What the numbers say: Deepak Nitrite Ltd leads with ₹551 crore of TTM profit, 480% above Archean Chemical Industries Ltd. Fischer Medical Ventures Ltd shows ≥100% on the scoring scale (2508.4% uncapped) growth from a ₹31 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.

LeaderDeepak Nitrite Ltd · ₹551 crore
Gap480% versus #2 · Archean Chemical Industries Ltd
Persistence3/8 recent comparable periods
Coverage9/9 companies · 134 observations

Investor read: Deepak Nitrite Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.

Net profit is the residual after operating costs, interest and tax. Growth off a loss or near-zero base is excluded from the fastest-grower rank.
Net profitlargest
1Deepak Nitrite Ltd DEEPAKNTR₹551 Cr
2Archean Chemical Industries Ltd ACI₹95 Cr
3Sree Rayalaseema Hi-Strength Hypo Ltd SRHHYPOLTD⚠ unverified₹89 Cr
4Ganesh Benzoplast Ltd GANESHBE⚠ unverified₹73 Cr
5J.G.Chemicals Ltd JGCHEM⚠ unverified₹68 Cr
Profit growthfastest growers
1Fischer Medical Ventures Ltd FISCHER100%
2Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified19%
3J.G.Chemicals Ltd JGCHEM⚠ unverified1.5%
4Sree Rayalaseema Hi-Strength Hypo Ltd SRHHYPOLTD⚠ unverified1.1%
5Deepak Nitrite Ltd DEEPAKNTR-21%
Net profit · company comparison
9/9 level · 7/9 change
All-company data · latest reported quarter
CompanyNet profitProfit growthReported
Deepak Nitrite Ltd DEEPAKNTR₹220 Cr8.9%Mar 2026
Archean Chemical Industries Ltd ACI₹30 Cr-25%Jun 2026
Sree Rayalaseema Hi-Strength Hypo Ltd SRHHYPOLTD⚠ unverified₹20 Cr-9.1%Mar 2026
J.G.Chemicals Ltd JGCHEM⚠ unverified₹19 Cr19%Mar 2026
Tanfac Industries Ltd TANFACIND₹17 Cr-11%Jun 2026
Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified₹15 Cr50%Mar 2026
Ganesh Benzoplast Ltd GANESHBE⚠ unverified₹15 Cr-11%Mar 2026
POCL Enterprises Ltd 539195₹13 Cr18%Mar 2026
Fischer Medical Ventures Ltd FISCHER₹-7 Cr-642%Mar 2026
Full 20-quarter history · every available company

Net profit · reported quarter history

Archean Chemical Industries Ltd · ACI

—
₹49 Cr
₹82 Cr
₹84 Cr
₹64 Cr
₹98 Cr
₹137 Cr
₹94 Cr
₹66 Cr
₹102 Cr
₹58 Cr
₹45 Cr
₹16 Cr
₹48 Cr
₹54 Cr
₹40 Cr
₹29 Cr
₹24 Cr
₹12 Cr
₹30 Cr

Deepak Nitrite Ltd · DEEPAKNTR

₹254 Cr
₹242 Cr
₹267 Cr
₹235 Cr
₹174 Cr
₹209 Cr
₹234 Cr
₹150 Cr
₹205 Cr
₹202 Cr
₹254 Cr
₹203 Cr
₹194 Cr
₹98 Cr
₹202 Cr
₹112 Cr
₹119 Cr
₹100 Cr
₹220 Cr
—

Fischer Medical Ventures Ltd · FISCHER

₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹-0 Cr
₹0 Cr
₹-0 Cr
₹0 Cr
₹-0 Cr
₹3 Cr
₹-0 Cr
₹0 Cr
₹-0 Cr
₹1 Cr
₹5 Cr
₹14 Cr
₹19 Cr
₹-7 Cr
—

Ganesh Benzoplast Ltd · GANESHBE⚠ unverified

—
—
—
—
₹14 Cr
₹15 Cr
₹15 Cr
₹15 Cr
₹16 Cr
₹16 Cr
₹14 Cr
₹16 Cr
₹16 Cr
₹18 Cr
₹-13 Cr
₹18 Cr
₹24 Cr
₹16 Cr
₹15 Cr
—

Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified

—
—
—
—
—
₹14 Cr
₹13 Cr
₹10 Cr
₹9 Cr
₹8 Cr
₹11 Cr
₹14 Cr
₹9 Cr
₹9 Cr
₹10 Cr
₹10 Cr
₹16 Cr
₹9 Cr
₹15 Cr
—

J.G.Chemicals Ltd · JGCHEM⚠ unverified

—
—
—
—
—
—
₹12 Cr
₹4 Cr
₹4 Cr
₹11 Cr
₹14 Cr
₹16 Cr
₹17 Cr
₹18 Cr
₹16 Cr
₹16 Cr
₹15 Cr
₹18 Cr
₹19 Cr
—

POCL Enterprises Ltd · 539195

—
—
—
—
—
—
—
—
—
—
—
₹6 Cr
—
—
₹11 Cr
₹11 Cr
₹8 Cr
₹9 Cr
₹13 Cr
—

Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified

—
—
—
—
—
₹24 Cr
₹71 Cr
₹24 Cr
₹18 Cr
₹17 Cr
₹20 Cr
₹19 Cr
₹25 Cr
₹22 Cr
₹22 Cr
₹22 Cr
₹23 Cr
₹24 Cr
₹20 Cr
—

Tanfac Industries Ltd · TANFACIND

—
—
—
—
—
₹16 Cr
₹22 Cr
₹18 Cr
₹11 Cr
₹10 Cr
₹13 Cr
₹11 Cr
₹19 Cr
₹35 Cr
₹23 Cr
₹19 Cr
₹17 Cr
₹16 Cr
₹18 Cr
₹17 Cr

Profit growth · reported quarter history

Archean Chemical Industries Ltd · ACI

—
—
925%
342%
—
100%
67%
12%
3.1%
4.1%
-58%
-52%
-76%
-53%
-6.9%
-11%
81%
-50%
-78%
-25%

Deepak Nitrite Ltd · DEEPAKNTR

—
—
—
-22%
-32%
-14%
-12%
-36%
18%
-3.4%
8.6%
35%
-5.4%
-51%
-20%
-45%
-39%
2.0%
8.9%
—

Fischer Medical Ventures Ltd · FISCHER

—
—
—
—
—
—
—
—
—
—
2,058%
—
—
—
-49%
—
4,693%
—
-642%
—

Ganesh Benzoplast Ltd · GANESHBE⚠ unverified

—
—
—
—
—
—
—
—
14%
6.7%
-6.7%
6.7%
0.0%
13%
-193%
13%
50%
-11%
—
—

Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified

—
—
—
—
—
—
—
—
—
-42%
-15%
40%
0.0%
13%
-9.1%
-29%
78%
0.0%
50%
—

J.G.Chemicals Ltd · JGCHEM⚠ unverified

—
—
—
—
—
—
—
—
—
—
17%
300%
325%
64%
14%
0.0%
-12%
0.0%
19%
—

POCL Enterprises Ltd · 539195

—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
83%
—
—
18%
—

Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified

—
—
—
—
—
—
—
—
—
-29%
-72%
-21%
39%
29%
10%
16%
-8.0%
9.1%
-9.1%
—

Tanfac Industries Ltd · TANFACIND

—
—
—
—
—
—
—
—
—
-38%
-41%
-39%
73%
250%
77%
73%
-11%
-54%
-22%
-11%
09 · compare level, then change

Return On Capital Employed

POCL Enterprises Ltd has the highest ROCE among the 9 Chemicals - Inorganic companies compared here, at 26.4%. Tanfac Industries Ltd is next at 23.7%. Fischer Medical Ventures Ltd has the highest ROCE change at +9.2 percentage points, so level and change sit with different companies. 9 of 9 companies report a comparable reading, the latest through Mar 2026.

What the numbers say: POCL Enterprises Ltd leads ROCE at 26.4%, 2.7 percentage points above Tanfac Industries Ltd. Fischer Medical Ventures Ltd has the strongest latest improvement at +9.2 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.

LeaderPOCL Enterprises Ltd · 26.4%
Gap11.4% versus #2 · Tanfac Industries Ltd
PersistenceNot enough history
Coverage9/9 companies · 104 observations

Investor read: POCL Enterprises Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current roce change signal.

ROCE asks how much operating return the business earns on the capital employed. Direction matters, but a single exceptional year should not be mistaken for durability.
ROCEhighest
1POCL Enterprises Ltd 53919526%
2Tanfac Industries Ltd TANFACIND24%
3J.G.Chemicals Ltd JGCHEM⚠ unverified18%
4Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified15%
5Ganesh Benzoplast Ltd GANESHBE⚠ unverified15%
ROCE changefastest improvers
1Fischer Medical Ventures Ltd FISCHER+9.2 pp
2Sree Rayalaseema Hi-Strength Hypo Ltd SRHHYPOLTD⚠ unverified−0.9 pp
3Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified−2.3 pp
4Deepak Nitrite Ltd DEEPAKNTR−2.9 pp
5J.G.Chemicals Ltd JGCHEM⚠ unverified−2.9 pp
Return on capital · company comparison
9/9 level · 8/9 change
All-company data · latest reported quarter
CompanyROCEROCE changeReported
J.G.Chemicals Ltd JGCHEM⚠ unverified14%−2.9 ppMar 2026
Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified12%−2.3 ppMar 2026
Deepak Nitrite Ltd DEEPAKNTR10%−2.9 ppMar 2026
Ganesh Benzoplast Ltd GANESHBE⚠ unverified9.9%−3.9 ppMar 2026
Fischer Medical Ventures Ltd FISCHER9.7%+9.2 ppMar 2026
Sree Rayalaseema Hi-Strength Hypo Ltd SRHHYPOLTD⚠ unverified7.7%−0.9 ppMar 2026
Archean Chemical Industries Ltd ACI6.6%−4.1 ppJun 2026
Full 20-quarter history · every available company

ROCE · reported quarter history

Archean Chemical Industries Ltd · ACI

—
—
26%
34%
—
—
36%
—
30%
35%
21%
21%
15%
13%
11%
11%
9.9%
10%
6.6%
—

Deepak Nitrite Ltd · DEEPAKNTR

44%
—
39%
—
32%
—
26%
—
23%
25%
19%
25%
17%
19%
13%
14%
9.8%
12%
10%
—

Fischer Medical Ventures Ltd · FISCHER

-138%
—
83%
—
54%
—
5.0%
—
8.4%
-4.5%
2.0%
3.5%
1.7%
8.1%
0.5%
6.2%
5.4%
22%
9.7%
—

Ganesh Benzoplast Ltd · GANESHBE⚠ unverified

17%
—
14%
—
15%
—
16%
22%
16%
20%
13%
17%
12%
17%
14%
10%
13%
11%
9.9%
—

Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified

28%
—
23%
—
23%
—
25%
—
20%
21%
15%
20%
15%
20%
14%
17%
12%
18%
12%
—

J.G.Chemicals Ltd · JGCHEM⚠ unverified

—
—
—
11%
22%
26%
33%
—
—
16%
10%
20%
16%
25%
17%
21%
15%
19%
14%
—

Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified

18%
—
22%
—
20%
—
20%
—
17%
20%
12%
13%
10%
14%
8.6%
13%
7.9%
12%
7.7%
—

ROCE change · reported quarter history

Archean Chemical Industries Ltd · ACI

—
—
—
—
—
—
+9.4 pp
—
—
—
−15.3 pp
—
−14.9 pp
−22.2 pp
−9.8 pp
−9.9 pp
−5.1 pp
−2.5 pp
−4.1 pp
—

Deepak Nitrite Ltd · DEEPAKNTR

—
—
—
—
−12.7 pp
—
−12.8 pp
—
−9.0 pp
—
−7.9 pp
—
−5.4 pp
−6.0 pp
−5.2 pp
−10.5 pp
−7.4 pp
−7.7 pp
−2.9 pp
—

Fischer Medical Ventures Ltd · FISCHER

—
—
—
—
+191.6 pp
—
−77.7 pp
—
−45.4 pp
—
−3.0 pp
—
−6.7 pp
+12.6 pp
−1.5 pp
+2.7 pp
+3.7 pp
+14.3 pp
+9.2 pp
—

Ganesh Benzoplast Ltd · GANESHBE⚠ unverified

—
—
—
—
−1.7 pp
—
+1.7 pp
—
+1.2 pp
—
−3.0 pp
−4.9 pp
−4.4 pp
−2.8 pp
+0.7 pp
−7.0 pp
+1.0 pp
−6.4 pp
−3.9 pp
—

Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified

—
—
—
—
−5.1 pp
—
+1.5 pp
—
−2.7 pp
—
−9.8 pp
—
−5.5 pp
−1.1 pp
−0.8 pp
−3.3 pp
−2.9 pp
−2.0 pp
−2.3 pp
—

J.G.Chemicals Ltd · JGCHEM⚠ unverified

—
—
—
—
—
—
—
—
—
−9.8 pp
−22.6 pp
—
—
+9.0 pp
+7.0 pp
+0.8 pp
−1.0 pp
−6.7 pp
−2.9 pp
—

Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified

—
—
—
—
+2.2 pp
—
−2.4 pp
—
−3.5 pp
—
−8.1 pp
—
−6.6 pp
−6.8 pp
−3.2 pp
+0.8 pp
−2.2 pp
−1.4 pp
−0.9 pp
—
10 · compare level, then change

Valuation Against Growth & Quality

Deepak Nitrite Ltd has the lowest PEG among the 9 Chemicals - Inorganic companies compared here, at 0.61×. Archean Chemical Industries Ltd is next at 0.83×. Sree Rayalaseema Hi-Strength Hypo Ltd has the lowest P/E at 8.29×, so level and change sit with different companies. 2 of 9 companies report a comparable reading, the latest through Mar 2026.

What the numbers say: Deepak Nitrite Ltd has the lowest comparable PEG at 0.61×, 26.5% below Archean Chemical Industries Ltd. Only 2 of 9 companies have earnings and growth steady enough for the ratio to mean anything, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.

LeaderDeepak Nitrite Ltd · 0.61×
Gap26.5% versus #2 · Archean Chemical Industries Ltd
Persistence0/8 recent comparable periods
Coverage2/9 companies · 3 observations

Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.

This conclusion weakens if: The next two comparable reports reverse the current p/e signal.

PEG is shown only when earnings are positive and three-year EPS growth is between 5% and 60%. It is recomputed consistently as the trailing P/E divided by that growth rate — reported earnings, never an expected-earnings multiple. On Indian companies it is shown only where the two data feeds agreed. Where any of that fails the ratio is left out rather than printed: a P/E divided by a loss, or by growth measured off a tiny base, is a number that looks precise and means nothing.
PEGlowest PEG
1Deepak Nitrite Ltd DEEPAKNTR0.6
2Archean Chemical Industries Ltd ACI0.8
P/Elowest P/E
1Sree Rayalaseema Hi-Strength Hypo Ltd SRHHYPOLTD⚠ unverified8.3
2Ganesh Benzoplast Ltd GANESHBE⚠ unverified12.1
3POCL Enterprises Ltd 53919512.8
4J.G.Chemicals Ltd JGCHEM⚠ unverified30.0
5Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified33.1
Valuation · company comparison
2/9 level · 9/9 change
All-company data · latest reported quarter
CompanyPEGP/EReported
Archean Chemical Industries Ltd ACI0.862.6Jun 2026
Deepak Nitrite Ltd DEEPAKNTR0.633.9Mar 2026
POCL Enterprises Ltd 539195—11.2Mar 2026
Tanfac Industries Ltd TANFACIND—68.5Jun 2026
Fischer Medical Ventures Ltd FISCHER—63.9Mar 2026
J.G.Chemicals Ltd JGCHEM⚠ unverified—19.8Mar 2026
Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified—19.9Mar 2026
Sree Rayalaseema Hi-Strength Hypo Ltd SRHHYPOLTD⚠ unverified—7.2Mar 2026
Ganesh Benzoplast Ltd GANESHBE⚠ unverified—6.8Mar 2026
Full 20-quarter history · every available company

PEG · reported quarter history

Archean Chemical Industries Ltd · ACI

—
—
—
—
—
—
0.8
—
—
—
—
—
—
—
—
—
—
—
—
—

Deepak Nitrite Ltd · DEEPAKNTR

—
2.7
—
0.6
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—

P/E · reported quarter history

Archean Chemical Industries Ltd · ACI

—
—
—
—
—
27.1
33.5
27.6
17.7
20.3
20.7
27.4
31.8
32.3
32.1
44.4
44.9
38.2
51.3
62.6

Deepak Nitrite Ltd · DEEPAKNTR

34.6
31.9
27.9
23.0
27.8
29.5
28.4
34.8
37.7
42.4
36.6
45.3
49.0
44.3
39.2
38.8
41.5
45.3
33.9
—

Fischer Medical Ventures Ltd · FISCHER

—
—
—
—
—
—
-39.8
—
3,711.1
—
1,830.9
2,123.3
2,115.7
2,333.0
1,795.4
4,328.0
1,135.5
137.8
63.9
—

Ganesh Benzoplast Ltd · GANESHBE⚠ unverified

26.4
52.3
62.4
21.5
21.9
19.9
20.9
17.5
16.6
17.5
19.7
16.5
16.4
15.1
11.5
8.7
7.6
7.0
6.8
—

Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified

15.5
11.4
10.7
9.2
10.8
10.4
6.9
8.6
10.7
16.0
12.9
14.5
16.3
13.8
12.5
15.9
19.2
21.8
19.9
—

J.G.Chemicals Ltd · JGCHEM⚠ unverified

—
—
—
—
—
—
—
—
—
—
10.1
13.8
50.2
28.0
19.1
24.5
24.8
22.3
19.8
—

POCL Enterprises Ltd · 539195

—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
21.0
18.1
11.2
—

Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified

8.8
8.2
10.3
6.9
11.4
7.1
5.8
8.0
7.3
7.0
6.3
10.9
15.8
15.8
9.5
12.5
10.2
9.4
7.2
—

Tanfac Industries Ltd · TANFACIND

17.3
13.5
12.4
9.2
20.5
23.4
24.5
34.4
29.4
36.0
31.6
41.0
43.9
56.2
37.1
41.7
47.9
44.1
51.3
68.5
11 · before the conclusion, check the blind spots

What can make this comparison misleading?

This Chemicals - Inorganic comparison names 6 specific ways its own evidence can mislead, all listed below. All 9 companies here report on comparable dates, so no rank carries a stale marker. 4 draw at least one figure from a second feed with too little overlap to cross-check. A high growth rate can still be a low-base artefact.

Keep these limits visible

  • A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
  • A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
  • The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
  • An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
  • 4 companies draw at least one figure from a second data feed with too little overlapping history to cross-check against the primary source; they are marked unverified wherever those figures appear.
  • Thin comparisons: Valuation have fewer than three usable current readings.
12 · evidence and freshness

How was this comparison built?

This comparison is built from the reported filings of 9 Chemicals - Inorganic companies, normalized to a common ₹ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-07-31. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.

FundamentalsThrough Jun 2026 · up to 20 quarters per company
Market dataThrough 2026-07-31 · weekly price and relative-strength history
Derived metricsGrowth, changes and PEG are calculated only when their inputs are comparable.
Score confidenceMissing and stale evidence reduces confidence and pulls the 0–100 research-priority score toward neutral.
Source standing3 cross-checked · 6 unverified · 0 withheld, of 9 graded companies.
How a second data feed is admitted, and what happens when it disagrees

A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree the figures fill silently. Where there is too little shared history to compare, the figures are still drawn — they are the only evidence there is — and marked ⚠ unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from.

13 · questions investors ask, short speakable answers

Chemicals - Inorganic company comparison FAQs

These 24 answers restate the Chemicals - Inorganic comparison above in question form. Every one is computed from the same 9 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-07-31. Nothing here is estimated, and none of it is a recommendation.

Is the Chemicals - Inorganic sector outperforming NIFTY 500?

Chemicals - Inorganic has underperformed NIFTY 500 by 7.1% over 52 weeks and 6.6% over 13 weeks. 4 of 9 covered companies beat NIFTY on Mansfield relative strength, while 2 of 9 beat the sector itself.

Which Chemicals - Inorganic company is largest by revenue?

Deepak Nitrite Ltd leads with revenue of ₹7,887 crore, based on 9 of 9 comparable companies through Mar 2026.

Which Chemicals - Inorganic company is growing fastest?

Fischer Medical Ventures Ltd has the fastest current revenue growth at 100%, across 8 of 9 comparable companies.

Which Chemicals - Inorganic company has the strongest 4-Factor Sector Score?

Indo Borax & Chemicals Ltd ranks first at 66.5/100 with 82.8% evidence confidence. The score prioritizes research; it is not a buy recommendation.

Which Chemicals - Inorganic company has the lowest comparable PEG?

Deepak Nitrite Ltd has the lowest comparable PEG at 0.61, among 2 of 9 companies whose earnings and growth are steady enough for the ratio to mean anything.

How much history does this Chemicals - Inorganic comparison include?

The page compares up to 20 reported quarters per company for fundamentals, returns and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.

How is the 4-Factor Sector Score calculated?

The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.

What is the Nifty Chemicals - Inorganic index?

The Nifty Chemicals - Inorganic index tracks India's listed Chemicals - Inorganic companies as a single basket. This page follows the same 9 companies and equal-weights them, so every company's weekly return counts once whatever it is worth, and the reading belongs to the Chemicals - Inorganic sector rather than to its largest constituent. Figures are as of Jun 2026.

Which are the best Chemicals - Inorganic stocks in India?

Ranked by this page's four-factor score, Indo Borax & Chemicals Ltd places first among 9 listed Chemicals - Inorganic companies, followed by Tanfac Industries Ltd. That is a ranking of published data — earnings, quality, valuation and market behaviour as of Jun 2026 — and not a recommendation; Sector Alpha is not registered with SEBI as an investment adviser.

How many Chemicals - Inorganic stocks are listed in India?

This comparison covers 9 listed Chemicals - Inorganic companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Jun 2026.

Which Chemicals - Inorganic company is the biggest?

Deepak Nitrite Ltd is the largest, with trailing-twelve-month revenue of ₹7,887 crore, ahead of POCL Enterprises Ltd at ₹1,431 crore. That covers 9 of 9 companies with comparable reporting through Mar 2026.

Which Chemicals - Inorganic company has the best profit margins?

Archean Chemical Industries Ltd has the highest operating margin at 21%, from 9 of 9 comparable companies. Deepak Nitrite Ltd shows the biggest recent improvement, at +3 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.

Which Chemicals - Inorganic company makes the most profit?

Deepak Nitrite Ltd earns the most, at ₹551 crore of trailing-twelve-month net profit, from 9 of 9 comparable companies. Fischer Medical Ventures Ltd has the fastest profit growth at 100%, though growth off a small or recovering profit base overstates how much has actually changed.

Which Chemicals - Inorganic company earns the highest return on capital?

POCL Enterprises Ltd leads on return on capital employed at 26.4%, across 9 of 9 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.

Which Chemicals - Inorganic stock is the cheapest?

On PEG — where a LOWER number is cheaper — Deepak Nitrite Ltd screens cheapest at 0.61×. Only 2 of 9 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.

Is the Chemicals - Inorganic sector beating the market?

Chemicals - Inorganic has underperformed NIFTY 500 by 7.1% over the last 52 weeks and 6.6% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 4 of 9 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.

Which Chemicals - Inorganic stock has the strongest price momentum?

Tanfac Industries Ltd has the strongest relative strength against NIFTY 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.

Which Chemicals - Inorganic company scores highest for research priority?

Indo Borax & Chemicals Ltd scores 66.5 out of 100 with 82.8% evidence confidence, from 23.4 points on growth and earnings, 17.6 on capital efficiency, 6.6 on valuation and 18.9 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.

How many Chemicals - Inorganic companies does this comparison cover, and over what period?

It compares 9 listed companies over up to 20 reported quarters of fundamentals, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.

What is the total market cap of the Chemicals - Inorganic sector?

The 9 Chemicals - Inorganic companies on this page carry ₹43,572 crore of combined market value. Deepak Nitrite Ltd is the largest at ₹22,671 crore, about 52% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-08-05.

What is the Chemicals - Inorganic sector's P/E ratio?

The median price-to-earnings ratio across the 9 Chemicals - Inorganic companies on this page is 33.1×, measured on the 9 that report a comparable figure. A sector-level history for this multiple is not held here, so this is a cross-section of today, not a comparison with the sector’s own past. Figures are as of 2026-08-05.

How is the Chemicals - Inorganic sector performing?

4 of the 9 covered Chemicals - Inorganic companies are beating NIFTY 500 on Mansfield relative strength. The sector itself is 7.1% behind NIFTY 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-08-05.

Why are some values on this page blank?

A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.

Is this investment advice?

No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI